The Bamberg Higher Regional Court has ordered the pharmaceutical company AstraZeneca to provide information about the possible effects of its corona vaccine. In the appeal process regarding alleged vaccine damage, AstraZeneca must disclose which effects and side effects of the vaccine the company was aware of between December 27, 2020 and February 19, 2024, a court spokesman said. The AstraZeneca vaccine was approved on December 27, 2020.
A 33-year-old woman blames AstraZeneca for possible vaccine damage. A vaccination in March 2021 caused her a coma, thrombosis and permanent intestinal damage. Among other things, the plaintiff was in the intensive care unit and parts of her small intestine had to be surgically removed. She is demanding compensation and damages from AstraZeneca.
The Hof regional court rejected their claims in the first instance. The claim for information, which the court in Bamberg upheld, was added in the course of the proceedings.
More on the topic: Corona vaccination and vaccine damage
Vaccine damage: The vaccination and suspicion
Vaccine damage: Nobody wants to pay for their vaccination damage
mRNA vaccines: What the wrong proteins are all about
Decision on compensation and damages in a few months
The court has not yet made a decision on the plaintiff’s claims; initially it only dealt with her additional lawsuit for information. This was successful with the partial verdict. The court did not allow an appeal of its judgment, although an appeal against non-admission could possibly be lodged with the Federal Court of Justice in Karlsruhe.
According to the ruling from this Monday, AstraZeneca must also disclose any other findings that could be “important for assessing the acceptability of harmful effects” of the vaccine. However, this obligation only applies to effects that affect the so-called thrombosis with thrombocytopenia syndrome.
© ZEIT ONLINE
Newsletter
New: Finally Monday
By registering, you acknowledge the data protection declaration.
Thank you! We have sent you an email.
Check your mailbox and confirm your newsletter subscription.
According to the court, the proceedings regarding the plaintiff’s claims for pain and suffering and damages are continuing. After the responsible Senate receives the information requested by AstraZeneca, a decision will be made as to whether an expert opinion should be obtained. A decision can be expected in a few months.
The plaintiff’s defense attorney expects further proceedings
The plaintiff’s lawyer said he and his client were very happy with the court’s decision. He assumes that this success will be followed by further claims for information in similar proceedings. In addition, the data that AstraZeneca now has to disclose could be relevant for other ongoing and future proceedings. The trial in Bamberg is one of the first trials against a corona vaccine manufacturer in Germany.
A total of around 65 million people in Germany were vaccinated against the coronavirus. Since then, 11,827 of them have submitted an application for recognition of vaccine damage, reported the Neue Osnabrücker Zeitung in January, citing a query with the relevant authorities. Up until then, such damage had been recognized in 467 cases. More than 5,000 applications were rejected, the others were resolved for other reasons or are still being processed.
The Bamberg Higher Regional Court has ordered the pharmaceutical company AstraZeneca to provide information about the possible effects of its corona vaccine. In the appeal process regarding alleged vaccine damage, AstraZeneca must disclose which effects and side effects of the vaccine the company was aware of between December 27, 2020 and February 19, 2024, a court spokesman said. The AstraZeneca vaccine was approved on December 27, 2020.
A 33-year-old woman blames AstraZeneca for possible vaccine damage. A vaccination in March 2021 caused her a coma, thrombosis and permanent intestinal damage. Among other things, the plaintiff was in the intensive care unit and parts of her small intestine had to be surgically removed. She is demanding compensation and damages from AstraZeneca.